Lake Forest, California-based Sonorous designed its BosCATH system to enhance access, delivery and procedural efficiency in complex cerebral venous and arterial anatomies.

The company said its device provides physicians with superior trackability, support and navigability in challenging neurovascular procedures.

FDA clearance comes on the heels of breakthrough device designation for its BosSTENT cerebral venous stent system as well. The company designed that braided, self-expanding stent to treat cerebral venous stenosis associated with debilitating pulsatile tinnitus. BosCATH adds to the Sonorous portfolio and supports the delivery of therapies like the BosSTENT in tortuous venous anatomy.